BELITE BIO, INC
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.
FY2025 · Filed Mar 31, 2026
BLTE$154.19+7.7%Stored close · as of Nov 6, 2026
Contents
ITEM 16B. Code of Ethics
Our Board of Directors adopted a code of business conduct and ethics (“Code of Conduct”) that applies to our directors, officers and employees in April 2022, as amended. The Code of Conduct is available under the “Corporate Governance” section of our website at https://investors.belitebio.com/
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.